Apolipoprotein E phenotypes, serum lipoproteins and apolipoproteins. in angiographically assessed coronary heart disease

References

• Mahley R W, Innerarity T L. Lipoprotein receptors and cholesterol homeostasis. Biochim Biophys Acta 1983; 737: 197–222
   PubMed Web of Science ®Google Scholar
• Havel R J, Chao Y, Windier E, Kotite L, Guo L SS. Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia. Proc Natl Acad Sci USA. 1980; 77: 4349–53
   PubMedGoogle Scholar
• Schneider W J, Kovanen P T, Brown M S, Goldstein J L, Utermann G, Weber W, Havel R J, Kotite L, Kane J P, Innerarity T L, Mahley R W. Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density receptors of human fibroblasts and membranes from liver and adrenals of human fibroblasts and membranes from liver and adrenals of rats, rabbits and cows. J Clin Invest 1981; 68: 1075–85
   PubMedGoogle Scholar
• Utermann G, Jaeschke M, Menzel J. Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very low density lipoproteins. FEBS Lett 1975; 56: 352–5
   PubMed Web of Science ®Google Scholar
• Zannis V I, Just P W, Breslow J L, Human Stuyi P. M. J. Apolipoprotein E isopoprotein subclasses are genetically determined. Am J Humn Genet 1981; 33: 11–24
   PubMed Web of Science ®Google Scholar
• Weisgraber K H, Rail R C, Mahley R W. Human apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apoE isoforms. J Biol Chem 1981; 256: 9077–83
   PubMed Web of Science ®Google Scholar
• McNzel H-J, Kladetzky R-G, Assmann G. Apolipoprotein E polymorphism and coronary heart disease. Arteriosclerosis 1983; 3: 310–5
   PubMedGoogle Scholar
• Utermann G, Kindermann H, Kaffarnik H, Steinmctz A. Apolipoprotein E phenotypes and hyperlipidemia. Hum Genet 1984; 65: 232–6
   PubMedGoogle Scholar
• Ehnholm C, Lukka M, Kuusi T, Nikkila E, Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res 1986; 27: 227–35
   PubMed Web of Science ®Google Scholar
• Morganroth J, Levy R I, Frcdrickson D. The biochemical, clinical and genetic features of type III hyperlipoproteinemia. Ann Int Med 1975; 82: 158–74
   PubMed Web of Science ®Google Scholar
• Utermann G, Vogelberg K H, Steinmetz A, Schoenborn W, Pruin N, Jaeschke M, Hees M, Canzler H. Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III. Clin Genet 1979; 15: 37–62
   PubMed Web of Science ®Google Scholar
• Utermann G, Pruin N, Steinmetz A. Polymorphism of apolipoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in man. Clin Genet 1979; 15: 63–72
   PubMed Web of Science ®Google Scholar
• Rail R C, Weisgraber K H, Innerarity T L, Mahley R W, Assmann G. Identical structural and receptor binding defects in apolipoprotein E2 in hypo-, normo- and hypercholesterolemic dys-betalipoproteincmia. J Clin Invest 1983; 71: 1023–1031
   PubMedGoogle Scholar
• Brcnninkmeijer B J, Stuyt P MJ, Demacker P NM, Stalenhoef A FH, van't Laar A. The catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype. J Lipid Res 1987; 28: 361–70
   PubMedGoogle Scholar
• Bouthillier D, Sing C F, Davignon J. Apolipoprotein E phenotyping with a single gel method: application to the study of informative matings. J Lipid Res 1983; 24: 1060–69
   PubMed Web of Science ®Google Scholar
• Sing C F, Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 1985; 37: 268–85
   PubMed Web of Science ®Google Scholar
• Eto M, Watanabc K, Ishii K. Reciprocal effects of apolipoprotein E alleles (E2 and e4) on plasma lipid levels in normolipidemic subjects. Clin Genet 1986; 29: 477–84
   PubMed Web of Science ®Google Scholar
• Assmann G, Schmitz G, Menzel H-J, Schulte H. Apolipoprotein E polymorphism and hyperlipidemia. Clin Chem 1984; 30: 641–3
   PubMedGoogle Scholar
• Leren T P, Borresen A-L, Berg K, Hjermann I, Leren P. Increased frequency of the apoliprotein E-4 isoform in male subjects with multifactorial hypercholesterolemia. Clin Genet 1985; 27: 458–62
   PubMedGoogle Scholar
• Cumming A M, Robertson F W. Polymorphism at the apolipoprotein-E locus in relation to the risk of coronary artery disease. Clin Genet 1984; 25: 310–3
   PubMed Web of Science ®Google Scholar
• Utermann G, Hardewig A, Zimmer F. Apolipoprotein E phenotypes in patients with myocardial infarction. Hum Genet 1984; 60: 237–41
   Google Scholar
• Kuusi T, Nieminen M S, Ehnholm C, Yki-Järvinen H, Valle M, Nikkilä E A, Taskinen M-J. Apoprotein E polymorphism and coronary heart disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis 1989; 9: 237–41
   PubMedGoogle Scholar
• Davignon J, Gregg R E, Sing C F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8: 1–21
   PubMedGoogle Scholar
• Shelburne F A, Ouarfordt S H. The interaction of heparin with an apoprotein of human very low density lipoprotein. J Clin Invest 1977; 60: 944–50
   PubMed Web of Science ®Google Scholar
• Demacker P NM, Hijmans A G, Vos-Janssen H E, van't Laar A. A study of the use of polyethylene glycol in estimating cholesterol in high density lipoprotein. Clin Chem 1980; 26: 1775–9
   PubMed Web of Science ®Google Scholar
• Beaumont J L, Carlson L A, Cooper G R, Fejfar Z, Fredrickson D S, Stasser T. Memoranda. Classification of hyperlipidaemias and hyperlipoprotein-aemias. Bull WHO 1970; 43: 891–908
   PubMed Web of Science ®Google Scholar
• Stalenhoef A FH, Casparie A F, Demacker P NM, Stouten J T, Lutterman J L, van't Laar A. Combined deficiency of apolipoprotein C-II and lipoprotein lipase in familial hyperchylomicrone-mia. Metabolism 1981; 30: 919–26
   PubMedGoogle Scholar
• Stuyt P MJ, Demacker P NM, van't Laar A. Serum lipids, lipoproteins and apolipoprotein E phenotypes in relatives of patients with type III hyperlipoproteinaemia. Eur J Clin Invest 1984; 14: 219–26
   PubMedGoogle Scholar
• Stuyt P MJ, Stalenhoef A FH, Demacker P NM, van't Laar A. A comparative study of the effects of acipimox and clofibrate in type HI and type IV hyperlipoproteinemia. Atherosclerosis 1985; 55: 51–62
   PubMedGoogle Scholar
• Hosmer D W, Lemershow S. Goodness-of-fit tests for the multiple logistic regression model. Comm Statistics 1980; A9: 1043–69
   Google Scholar
• Liu K, Dyer A R. A rank statistic for assessing the amount of variation explained by risk factors in epidemiologic studies. Am J Epidemiol 1979; 109: 597–606
   PubMedGoogle Scholar
• Green M S. Evaluating the discriminatory power of a multiple logistic regression model. Statistics in Medicine 1988; 7: 519–24
   PubMed Web of Science ®Google Scholar
• Lenzen H J, Assmann G, Buchwalsky R, Schulte H. Association of apolipoprotein E polymorphism, low-density cholesterol, and coronary artery disease. Clin Chem 1986; 32: 778–81
   PubMed Web of Science ®Google Scholar
• Schmidt S B, Wasserman A G, Muesing R A, Schlesselman S E, La-Rosa J C, Roos A M. Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis. Am J Card 1985; 71: 1459–62
   Google Scholar
• Reardon M F, Nestel P J, Craig I H, Harper R W. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation 1985; 71: 881–8
   PubMed Web of Science ®Google Scholar
• Kameda K, Matsuzawa Y, Kubo M, Ishikawa K, Maejima I, Yamamura T, Yamamoto A, Tarui S. Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan. Atherosclerosis 1984; 51: 241–9
   PubMed Web of Science ®Google Scholar
• Stalenhoef A FH, Malloy M J, Kane J P, Havel R J. Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in patients with familial dysbetalipoproteinemia. J Clin Invest 1986; 78: 722–8
   PubMedGoogle Scholar
• Weintraub M S, Eisenberg S, Breslow J L. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 1987; 80: 1571–7
   PubMedGoogle Scholar